SCHEMBL4972190

SCHEMBL4972190

CNC(C(C)NC(=O)OCc1ccccc1)C1(C)CCCCC1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 13/20 0.48
TSHR P16473 10/20 0.48
ALDH1A1 P00352 5/20 0.48
CYP2C9 P11712 6/20 0.47
CYP2C19 P33261 5/20 0.47
CYP1A2 P05177 4/20 0.47
SMN1; SMN2 Q16637 4/20 0.47
CYP2D6 P10635 2/20 0.47
LMNA P02545 3/20 0.47
MEN1 O00255 2/20 0.47
KMT2A Q03164 2/20 0.47
ATM Q13315 1/20 0.46
MAPK1 P28482 2/20 0.46
HSD17B10 Q99714 1/20 0.46
CTSL P07711 1/20 0.46
CTSB P07858 1/20 0.46
CTSS P25774 1/20 0.46
CASP1 P29466 1/20 0.45
CTSK P43235 2/20 0.45
ELANE P08246 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4971348 0.86 CYP3A4 (0.50) CYP3A4TSHRALDH1A1CYP2C9CYP2C19
SCHEMBL4971545 0.81 CYP3A4 (0.46) CYP3A4TSHRALDH1A1CYP2C9CYP2C19
SCHEMBL8267044 0.80 CYP3A4 (0.52) CYP3A4TSHRALDH1A1CYP2C9CYP2C19
SCHEMBL5605395 0.79 CASP1 (0.50) CYP3A4TSHRALDH1A1CYP2C9CYP2C19
SCHEMBL12937431 0.78 CYP3A4 (0.47) CYP3A4TSHRALDH1A1CYP2C9CYP2C19
SCHEMBL5605686 0.77 CASP1 (0.51) CYP3A4TSHRALDH1A1CYP2C9CYP2C19
SCHEMBL5605738 0.75 CYP3A4 (0.48) CYP3A4TSHRALDH1A1CYP2C9CYP2C19
SCHEMBL14704026 0.75 ATM (0.61) ATMCTSLCTSBCTSSCTSK
SCHEMBL6841166 0.75 ATM (0.61) ATMCTSLCTSBCTSSCTSK
SCHEMBL12942877 0.75 ATM (0.61) ATMCTSLCTSBCTSSCTSK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1966139-A1 ASPARTIC PROTEASE INHIBITORS Vitae Pharmaceuticals, Inc. (US) 2008-09-10 EP disclosed
WO-2007070201-A1 ASPARTIC PROTEASE INHIBITORS VITAE PHARMACEUTICALS, INC. (US) 2007-06-21 WO disclosed